Scar
3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GaldermaBotulinum Toxins
Innovo TherapeuticsINV-001
AbbVieBotulinum Toxin Type A
Clinical Trials (3)
Total enrollment: 137 patients across 3 trials
The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation
Start: Jun 2019Est. completion: Dec 202422 patients
Phase 2/3Completed
Ointment to Prevent Scar After Thyroidectomy
Start: Feb 2023Est. completion: Jun 202475 patients
Phase 2Unknown
Botox in the Healing of Surgical Wounds of the Neck
Start: May 2010Est. completion: May 201640 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.